PHN.MI
PHN.MI
IT0005274094
PHARMANUTRA
Loading chart...

Company Profile

Pharmanutra S.p.A., a nutraceutical company, engages in the research and development and marketing of food supplements and medical devices in Europe, the Middle East, Far East, North America, South America, and internationally. The company produces and distributes raw materials and active ingredients for the food, pharmaceutical, and dietary supplement industries. It offers Sucrosomial, a delivery system that optimises nutrient transport and absorption for minimising gastrointestinal side effects; and Cetylated Fatty Acids, a formulation for muscle and joint recovery in physiotherapy and sports. The company also sells instrumentation and software for body bioimpedance analysis through agents, distributors, and online sales. Pharmanutra S.p.A. was founded in 2000 and is headquartered in Pisa, Italy.

Related stocks

BIOG-B.ST
BIOG-B.ST • Sweden
BioGaia AB ser. B
116.8 SEK
1.18B USD 1Y +5.7%
ALVO
ALVO • Luxembourg
Alvotech
5.78 USD
2.06B USD 1Y -34.7%
FAGR.BR
FAGR.BR • Belgium
FAGRON
22.2 EUR
1.83B USD 1Y +10.1%
ALM.MC
ALM.MC • Spain
ALMIRALL S.A.
10.08 EUR
2.46B USD 1Y -15.5%
ROVI.MC
ROVI.MC • Spain
LABORATORIOS FARMACEUTICOS ROVI
58.05 EUR
3.33B USD 1Y -1.1%
PRGO
PRGO • Ireland
Perrigo Company plc
15.06 USD
2.09B USD 1Y -33%
EVT.DE
EVT.DE • Germany
Evotec SE I
2.77 EUR
551.16M USD 1Y -59%
PPGN.SW
PPGN.SW • Switzerland
POLYPEPTIDE N
43.85 CHF
1.74B USD 1Y +68.2%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
30.4% p.a.
Max Drawdown (5Y)
-50.4%
Sharpe Ratio (5Y)
0.00
Beta Factor
0.18
Size Class
Small Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (30.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -50.4% in the extended horizon.
ende